Inflammatory Biomarkers' Function in Cardiovascular Event Prediction

Authors

  • Shodiyev Mirshodbek Marufovich Bukhara state medical Institute,Assistant

Keywords:

hazard, events, cardiovascular

Abstract

The study's methodology involved enrolling 1,090 patients who had coronary angiography. Twenty-four indicators of inflammation were gathered before angiography. Distinct patterns of inflammatory biomarkers were identified by cluster analyses using unsupervised machine learning. The link between inflammatory biomarker clusters and individual biomarker associations with major adverse cardiovascular events (MACE; non-fatal myocardial infarction or stroke, and CV mortality) over a median follow-up of 3.67 years was evaluated using Cox proportional hazard regression.

References

Libby P. Atherosclerosis and inflammation. 2012;32:2045–51; Arterioscler Thromb Vasc Biol. 2.

Tedgui A, Mallat Z, Taleb S, and Ait-Oufella H. Recent developments on the part cytokines play in

atherosclerosis. 2011;31:969–79; Arterioscler Thromb Vasc Biol. October 2022, American Heart

Journal

Kalkman DN, Guedeney P, Claessen BE, et al. residual inflammatory risk in individuals

undergoing percutaneous coronary intervention who have low LDL cholesterol. 73:2401–9, J Am

Coll Cardiol, 2019.

Hansson GK, Libby P. The week's JACC review subject ranges from systemic inflammation to

localized lipid storage. 74:1594–607 in J Am Coll Cardiol, 2019.

Godoy LC, Bhatt DL, Lawler PR, et al. Clinical translation's next stages in addressing

cardiovascular inflammation. Eur Heart J 42:113–31, 2021.

Lyass A, Liu Y, Gaggin HK, et al. Myocardial infarction incident type 2 in a group of patients

receiving peripheral arterial or coronary angiography. Circulation 135:116–27, 2017.

Consoli A, Bain SC, Marso SP, et al. Cardiovascular outcomes and semaglutide in individuals with

type 2 diabetes. In 2016, N Engl J Med 375:1834–44.

Cavender MA, Abadie BQ, and Cannon CP. new oral anticoagulants after coronary artery bypass

surgery. Circ 2020; 13. Cardiovasc Interv 9. Stock JK. Future learning from studies on residual

inflammatory risk. In 2020, Atherosclerosis 311:103–4.

Libby P. The idea that inflammation causes atherosclerosis is no longer valid. 2021 Clin Chem

:131–42.

Everett BM, Thuren T, Ridker PM, et al. Canakinumab-based anti-inflammatory treatment for

atherosclerotic disease. N Engl J Med 377:1119–31, 2017.

IL-6 inhibition with ziltivekimab in patients at high atherosclerosis risk (RESCUE): a doubleblind, randomized, placebo-controlled, phase 2 study Ridker PM, Devalaraja M, Baeres FMM, et al.

Lancet 397:2060-9.

Deftereos SG, Shah B, Beerkens FJ, et al. Comprehensive overview of colchicine's role in

cardiovascular disease. Circulation 145:61–78, 2022.

Barraclough J, Robertson S, Martinez GJ, et al. Acute coronary syndrome patients' local cardiac

production of inflammatory cytokines is abruptly suppressed by colchicine. 15. Ridker PM, Everett

BM, Pradhan A, et al. J Am Heart Assoc 2015;4. Methotrexate at low doses to prevent atherosclerotic

events. 2019; N Engl J Med;380:752–62.

Ridker PM, Everett BM, MacFadyen JG, et al. A secondary analysis from the CANTOS

randomised controlled trial examined the relationship between the decrease in C-reactive protein

and the decrease in cardiovascular events after canakinumab medication. 2018;391:319–28;Lancet.

Qiao JH, Mishra NK, Tripathi J, et al. Studies on osteopetrotic mice reveal the role of macrophage

colony-stimulating factor in atherosclerosis. In 1997, Am J Pathol, 150:1687–99.

Zolindaki MG, Pentzeridis PC, Rallidis LS, et al. In severe unstable angina, elevated levels of

macrophage colony stimulating factor after the acute phase are highly indicative of long-term

results. Heart, 2004; 90:25–9.

Vasudevan SS, Kereiakes DJ, Seshiah PN, et al. The function of cell contact and macrophage

colony-stimulating factor in the smooth muscle cell death caused by activated monocytes.

Circulation 105:174–80, 2002.

Philippova M, Oskolkova O, Bochkov VN, et al. Through autocrine pathways, oxidized

phospholipids promote angiogenesis, suggesting a new function for lipid oxidation in the

development of atherosclerotic lesions. 2006;99:900–8; Circ Res.

Downloads

Published

2024-11-19

Issue

Section

Articles

How to Cite

Inflammatory Biomarkers’ Function in Cardiovascular Event Prediction. (2024). Journal of Pedagogical Inventions and Practices, 38, 5-13. https://mail.zienjournals.com/index.php/jpip/article/view/5805